• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

coats' 病患者房水中一氧化氮和血管内皮生长因子水平的增加。

Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease.

机构信息

Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, China.

出版信息

J Ocul Pharmacol Ther. 2012 Aug;28(4):397-401. doi: 10.1089/jop.2011.0168. Epub 2012 Jan 10.

DOI:10.1089/jop.2011.0168
PMID:22233441
Abstract

PURPOSE

To determine the aqueous humor levels of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in the eyes of patients with Coats' disease and study the correlation between these levels.

METHODS

Samples of aqueous humor were obtained from 7 patients with Coats' disease and 15 age-matched patients with congenital cataracts as controls. Nitrite and nitrate (NOx), the stable end products of NO, were detected by the Griess reaction, and VEGF levels were assessed by enzyme-linked immunosorbent assay.

RESULTS

The aqueous humor NOx and VEGF levels were elevated in the eyes of patients with Coats' disease compared with those of controls (P=0.001 and P<0.001, respectively). The median NOx level was 55.2 μM (range, 23.0-75.3 μM) in the Coats' disease group and 18.8 μM (range, 8.7-36.2 μM) in the control group. The median VEGF level was 731.7 pg/mL (range, 288.3-1364.3 pg/mL) in the Coats' disease group and 33.3 pg/mL (range, 9.0-96.8 pg/mL) in the control group. No correlation was observed between the aqueous humor concentrations of NOx and VEGF.

CONCLUSIONS

NOx and VEGF are increased but not related in the aqueous humor samples of patients with Coats' disease. NO and VEGF may play roles in the pathogenesis of Coats' disease. Further studies are needed to clearly elucidate the relationship among VEGF, NO, and other cytokines in Coats' disease.

摘要

目的

测定 coats 病患者眼内房水中一氧化氮(NO)和血管内皮生长因子(VEGF)的水平,并研究两者之间的相关性。

方法

收集 7 例 coats 病患者和 15 例年龄匹配的先天性白内障患者的房水样本作为对照。通过格里塞反应检测房水中的硝酸盐和亚硝酸盐(NOx),这是 NO 的稳定终产物,并用酶联免疫吸附试验测定 VEGF 水平。

结果

与对照组相比,coats 病患者眼内房水中的 NOx 和 VEGF 水平升高(P=0.001 和 P<0.001)。coats 病组的 NOx 中位数为 55.2 μM(范围,23.0-75.3 μM),对照组为 18.8 μM(范围,8.7-36.2 μM)。coats 病组的 VEGF 中位数为 731.7 pg/mL(范围,288.3-1364.3 pg/mL),对照组为 33.3 pg/mL(范围,9.0-96.8 pg/mL)。但在 coats 病患者的房水中,NOx 和 VEGF 的浓度之间没有相关性。

结论

NOx 和 VEGF 在 coats 病患者的房水中升高,但没有相关性。NO 和 VEGF 可能在 coats 病的发病机制中起作用。需要进一步的研究来阐明 coats 病中 VEGF、NO 和其他细胞因子之间的关系。

相似文献

1
Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease. coats' 病患者房水中一氧化氮和血管内皮生长因子水平的增加。
J Ocul Pharmacol Ther. 2012 Aug;28(4):397-401. doi: 10.1089/jop.2011.0168. Epub 2012 Jan 10.
2
Vascular endothelial growth factor in Coats' disease.科茨病中的血管内皮生长因子
Acta Ophthalmol. 2014 May;92(3):e225-8. doi: 10.1111/aos.12158. Epub 2013 Jun 13.
3
Associations of cytokine concentrations in aqueous humour with retinal vascular abnormalities and exudation in Coats' disease.房水细胞因子浓度与 Coats 病视网膜血管异常和渗出的关系。
Acta Ophthalmol. 2019 May;97(3):319-324. doi: 10.1111/aos.13971. Epub 2018 Nov 9.
4
Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.Coats 病血管内皮生长因子水平升高及其贝伐单抗的可能治疗作用。
Graefes Arch Clin Exp Ophthalmol. 2010 Oct;248(10):1519-21. doi: 10.1007/s00417-010-1366-1. Epub 2010 Apr 9.
5
Differences in aqueous concentrations of cytokines in paediatric and adult patients with Coats' disease.小儿与成人Coats病患者房水中细胞因子浓度的差异。
Acta Ophthalmol. 2017 Sep;95(6):608-612. doi: 10.1111/aos.13151. Epub 2016 Jun 30.
6
iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease.基于iTRAQ的Coats病患者房水蛋白质组学研究
PLoS One. 2016 Jul 14;11(7):e0158611. doi: 10.1371/journal.pone.0158611. eCollection 2016.
7
Levels of cytokines in the aqueous humor guided treatment of refractory macular edema in adult-onset coats' disease.房水细胞因子水平指导成人 Coats 病难治性黄斑水肿的治疗。
BMC Ophthalmol. 2020 Jun 30;20(1):261. doi: 10.1186/s12886-020-01474-1.
8
Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease.科茨病患者眼部房水细胞因子谱及其与疾病严重程度的关联。
BMC Ophthalmol. 2020 May 5;20(1):178. doi: 10.1186/s12886-020-01421-0.
9
Expression of vascular endothelial growth factor in eyes with Coats' disease.血管内皮生长因子在 Coats 病眼中的表达。
Invest Ophthalmol Vis Sci. 2013 Jan 7;54(1):57-62. doi: 10.1167/iovs.12-10613.
10
Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Drugs for Coats' Disease Treatment: A Systematic Review.抗血管内皮生长因子药物治疗 Coats 病的疗效和安全性:系统评价。
J Ocul Pharmacol Ther. 2023 Sep;39(7):418-429. doi: 10.1089/jop.2023.0028. Epub 2023 Jul 27.

引用本文的文献

1
Coats disease in infants, toddlers, and preschoolers: Clinical presentation and treatment outcomes.婴幼儿及学龄前儿童的科茨病:临床表现与治疗结果
Indian J Ophthalmol. 2025 May 1;73(5):672-678. doi: 10.4103/IJO.IJO_2477_24. Epub 2025 Apr 24.
2
A Brief Review on Adult-Onset Coats' Disease.成人型 Coats 病简述
Rom J Ophthalmol. 2024 Jul-Sep;68(3):212-218. doi: 10.22336/rjo.2024.40.
3
Treatment of Coats' disease: an analysis of pooled results.科茨病的治疗:汇总结果分析
Int J Ophthalmol. 2019 Apr 18;12(4):668-674. doi: 10.18240/ijo.2019.04.23. eCollection 2019.
4
Recent advances in the diagnosis and treatment of Coats' disease.科茨病诊断与治疗的最新进展
Int Ophthalmol. 2019 Apr;39(4):957-970. doi: 10.1007/s10792-019-01095-8. Epub 2019 Mar 20.
5
The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.抗血管内皮生长因子(VEGF)注射、激光凝固和冷冻疗法联合治疗对3型Coats病患者的疗效。
BMC Ophthalmol. 2017 May 22;17(1):76. doi: 10.1186/s12886-017-0469-4.
6
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.玻璃体内注射阿柏西普治疗1型黄斑毛细血管扩张症的疗效与眼部血管生成特征有关。
Retina. 2017 Dec;37(12):2226-2237. doi: 10.1097/IAE.0000000000001424.
7
iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease.基于iTRAQ的Coats病患者房水蛋白质组学研究
PLoS One. 2016 Jul 14;11(7):e0158611. doi: 10.1371/journal.pone.0158611. eCollection 2016.
8
The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.玻璃体腔内注射bevacizumab 作为 Coats 病初始治疗的效果。
Graefes Arch Clin Exp Ophthalmol. 2014 Jan;252(1):35-42. doi: 10.1007/s00417-013-2409-1. Epub 2013 Jul 20.